AAAAAA
Results: 1-25/26
Authors:
Tashkin, DP
Citation: Dp. Tashkin, The importance of control in asthma management: Do leukotriene receptor antagonists meet patient and physician needs?, ALL ASTH P, 22(5), 2001, pp. 311-319
Authors:
Roth, MD
Marques-Magallanes, JA
Yuan, M
Sun, WM
Tashkin, DP
Hankinson, O
Citation: Md. Roth et al., Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and Delta(9)-tetrahydrocannabinol, AM J RESP C, 24(3), 2001, pp. 339-344
Authors:
Tashkin, DP
Jamerson, BD
Patel, MK
Citation: Dp. Tashkin et al., Safety profile of bupropion for chronic obstructive pulmonary disease, LANCET, 358(9286), 2001, pp. 1009-1010
Authors:
Tashkin, DP
Kanner, R
Bailey, W
Buist, S
Anderson, P
Nides, MA
Gonzales, D
Dozier, G
Patel, MK
Jamerson, BD
Citation: Dp. Tashkin et al., Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial, LANCET, 357(9268), 2001, pp. 1571-1575
Authors:
Ziment, I
Tashkin, DP
Citation: I. Ziment et Dp. Tashkin, Adverse and allergic reactions in complementary and alternative medicine -Reply, J ALLERG CL, 108(1), 2001, pp. 150-150
Authors:
Sarafian, TA
Tashkin, DP
Roth, MD
Citation: Ta. Sarafian et al., Marijuana smoke and Delta(9)-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosis, TOX APPL PH, 174(3), 2001, pp. 264-272
Authors:
Chapman, KR
Tashkin, DP
Pye, DJ
Citation: Kr. Chapman et al., Gender bias in the diagnosis of COPD, CHEST, 119(6), 2001, pp. 1691-1695
Authors:
Simmons, MS
Tashkin, DP
Citation: Ms. Simmons et Dp. Tashkin, Compliance with bronchodilator treatment, CHEST, 119(3), 2001, pp. 989-989
Authors:
Littner, MR
Ilowite, JS
Tashkin, DP
Friedman, M
Serby, CW
Menjoge, SS
Witek, TJ
Citation: Mr. Littner et al., Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva)in stable chronic obstructive pulmonary disease, AM J R CRIT, 161(4), 2000, pp. 1136-1142
Authors:
Scanlon, PD
Connett, JE
Waller, LA
Altose, MD
Bailey, WC
Buist, AS
Tashkin, DP
Citation: Pd. Scanlon et al., Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease - The Lung Health Study, AM J R CRIT, 161(2), 2000, pp. 381-390
Authors:
Zhang, ZF
Morgenstern, H
Spitz, MR
Tashkin, DP
Yu, GP
Hsu, TC
Schantz, SP
Citation: Zf. Zhang et al., Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma, CANC EPID B, 9(10), 2000, pp. 1043-1049
Authors:
Tashkin, DP
Citation: Dp. Tashkin, HFA-BDP and its implications for the quiet zone, RESP MED, 94, 2000, pp. S37-S39
Authors:
Ziment, I
Tashkin, DP
Citation: I. Ziment et Dp. Tashkin, Alternative medicine for allergy and asthma, J ALLERG CL, 106(4), 2000, pp. 603-614
Authors:
Altose, MD
Redline, S
Deitz, CD
Quinlan, KJ
Eichenhorn, MS
Conway, WA
Jentons, RL
Braden, K
Ketchum, M
Wise, RA
Permutt, S
Rand, CS
Daniel, M
Santopietro, V
Weeks, KA
Scanlon, PD
Patel, AM
Utz, JP
Williams, DE
Caron, GM
Micras, KS
Buist, AS
Johnson, LR
Bortz, VJ
Persons, SL
Schueler, HA
Bailey, WC
Brooks, CM
Gerald, LB
Montiel, L
Tashkin, DP
Coulson, AH
Kleerup, EC
Li, VC
Nides, MA
Zuniga, IP
Lee, YE
Anthonisen, NR
Manfreda, J
Rempel-Rossum, SC
Stoyko, JM
Connett, JE
Kjelsberg, MO
Bollenbeck, MT
Kurnow, KJ
Madhok, TC
Skeans, MA
Voelker, HT
Rogers, RM
Owens, GR
Vitale, FM
Pusateri, ME
Kanner, RE
Villegas, GM
Esplin, C
Stayner, RS
Bascom, R
Landis, JR
Maurer, JR
Phillips, Y
Rennard, SI
Stoller, JK
Tager, I
Thomas, A
Hyatt, RE
Lambrew, CT
Mason, BA
Hurd, SS
Weinmann, G
Wu, MC
Citation: Md. Altose et al., Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease., N ENG J MED, 343(26), 2000, pp. 1902-1909
Authors:
Zhu, LX
Sharma, S
Stolina, M
Gardner, B
Roth, MD
Tashkin, DP
Dubinett, SM
Citation: Lx. Zhu et al., Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway, J IMMUNOL, 165(1), 2000, pp. 373-380
Authors:
Simmons, MS
Nides, MA
Rand, CS
Wise, RA
Tashkin, DP
Citation: Ms. Simmons et al., Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial, CHEST, 118(2), 2000, pp. 290-295
Authors:
Crapo, RO
Jensen, RL
Hegewald, M
Tashkin, DP
Citation: Ro. Crapo et al., Arterial blood gas reference values for sea level and an altitude of 1,400meters, AM J R CRIT, 160(5), 1999, pp. 1525-1531
Authors:
Zhang, ZF
Morgenstern, H
Spitz, MR
Tashkin, DP
Yu, GP
Marshall, JR
Hsu, TC
Schantz, SP
Citation: Zf. Zhang et al., Marijuana use and increased risk of squamous cell carcinoma of the head and neck, CANC EPID B, 8(12), 1999, pp. 1071-1078
Authors:
Tashkin, DP
Citation: Dp. Tashkin, Effects of marijuana on the lung and its defenses against infection and cancer, SCH PSY INT, 20(1), 1999, pp. 23-37
Authors:
Goldin, JG
Tashkin, DP
Kleerup, EC
Greaser, LE
Haywood, UM
Sayre, JW
Simmons, MD
Suttorp, M
Colice, GL
Burgt, JAV
Aberle, DR
Citation: Jg. Goldin et al., Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: Assessment with functional helical thin-section computed tomography, J ALLERG CL, 104(6), 1999, pp. S258-S267
Authors:
Tashkin, DP
Citation: Dp. Tashkin, Microelectronic adherence monitors for metered-dose inhalers: Who monitorsthe monitors?, J ALLERG CL, 104(1), 1999, pp. 22-24
Authors:
Tashkin, DP
Nathan, RA
Howland, WC
Minkwitz, MC
Simonson, SG
Bonuccelli, CM
Citation: Dp. Tashkin et al., An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses, J ALLERG CL, 103(2), 1999, pp. 246-254
Authors:
Tashkin, DP
Citation: Dp. Tashkin, Extra fine hydrofluoroalkane-134A beclomethasone aerosols - Selecting an optimal inhaled steroid for an individual patient, CHEST, 116(3), 1999, pp. 842-842
Authors:
Tashkin, DP
Citation: Dp. Tashkin, Extra-fine corticosteroid aerosols from hydrofluoroalkane-134a metered-dose inhalers - Potential advantages and disadvantages, CHEST, 115(2), 1999, pp. 316-318
Authors:
Tashkin, DP
Citation: Dp. Tashkin, Marihuana and the lung, MARIHUANA AND MEDICINE, 1999, pp. 279-287